Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1989 Mar;33(3):322-5.
doi: 10.1128/AAC.33.3.322.

Effects of elfamycins on elongation factor Tu from Escherichia coli and Staphylococcus aureus

Affiliations

Effects of elfamycins on elongation factor Tu from Escherichia coli and Staphylococcus aureus

C C Hall et al. Antimicrob Agents Chemother. 1989 Mar.

Abstract

Six kirromycin analogs (elfamycins) were compared on the basis of their inhibition of Escherichia coli poly(U)-directed poly(Phe) synthesis and stimulation of elongation factor Tu (EF-Tu)-associated GTPase activity. The elfamycins tested were kirromycin, aurodox, efrotomycin, phenelfamycin A, unphenelfamycin, and L-681,217. The last three lack the pyridone ring present in the other elfamycins. All the elfamycins inhibited poly(U)-dependent poly(Phe) synthesis and stimulated EF-Tu-associated GTPase activity, suggesting that the pyridone ring is not essential for activity. The six elfamycins were also examined in a poly(U)-directed, poly(Phe)-synthesizing system derived from Staphylococcus aureus and had 50% inhibitory concentrations of greater than or equal to 1 mM. When S. aureus ribosomes and E. coli elongation factors were combined in a hybrid poly(Phe)-synthesizing system, aurodox produced essentially complete inhibition of poly(Phe) synthesis with a 50% inhibitory concentration of 0.13 microM. This suggests that the observed high MICs of kirromycin and its congeners in S. aureus reflect a kirromycin-resistant EF-Tu rather than permeability constraints.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Antimicrob Agents Chemother. 1982 Jul;22(1):172-5 - PubMed
    1. J Antibiot (Tokyo). 1981 Aug;34(8):1039-45 - PubMed
    1. Annu Rev Microbiol. 1985;39:557-77 - PubMed
    1. J Antibiot (Tokyo). 1986 Oct;39(10):1361-7 - PubMed
    1. Biochemistry. 1987 Apr 7;26(7):2047-54 - PubMed

MeSH terms